Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://www.aan.com/msa/Public/Events/AbstractDetails/63135

Joaquim Ferreira1; Olivier Rascol2; Fabrizio Stocchi3; Angelo Antonini4; Bruno Dias5; Francisco Rocha5; Daniel Ramos5; Ghazal Banisadr6; Helena Brigas5; Joerg Holenz5; Werner Poewe7

Mar 6, 2026